Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
Condition(s) studied
Investigational drug(s) / intervention(s)
experimental in day hospital: multidisciplinary day hospital
taste and smell disorders questionnaire: Answer to the home-made questionnaire at inclusion and at 6 months
Study summary
Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet.
The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.
Eligibility
Primary outcome measure(s)
- difference in scores between 6 months and the inclusion at "taste and smell disorders" questionnaire — 6 months
taste and smell disorders home-made questionnaire (score from 0 to 100)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Médipôle Hôpital Mututaliste | Villeurbanne | France | Recruiting |
More Médipôle Lyon-Villeurbanne trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07041710 on ClinicalTrials.gov ↗ ← All trials in France